Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair.

Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, Nathans J.

Cell. 2004 Mar 19;116(6):883-95.

2.

Norrin and frizzled; a new vein for the eye.

Niehrs C.

Dev Cell. 2004 Apr;6(4):453-4. Review.

3.

Non-conventional Frizzled ligands and Wnt receptors.

Hendrickx M, Leyns L.

Dev Growth Differ. 2008 May;50(4):229-43. doi: 10.1111/j.1440-169X.2008.01016.x. Review.

PMID:
18366384
4.

Specificity of WNT-receptor interactions.

Hsieh JC.

Front Biosci. 2004 May 1;9:1333-8. Review.

PMID:
14977548
5.

Wnt signaling: an embarrassment of receptors.

Bejsovec A.

Curr Biol. 2000 Dec 14-28;10(24):R919-22. Review.

6.

Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight.

Masckauchán TN, Kitajewski J.

Physiology (Bethesda). 2006 Jun;21:181-8. Review.

7.

Norrin: molecular and functional properties of an angiogenic and neuroprotective growth factor.

Ohlmann A, Tamm ER.

Prog Retin Eye Res. 2012 May;31(3):243-57. doi: 10.1016/j.preteyeres.2012.02.002. Epub 2012 Feb 21. Review.

PMID:
22387751
8.

Wnt signaling: Ig-norrin the dogma.

Clevers H.

Curr Biol. 2004 Jun 8;14(11):R436-7. Review.

9.

LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.

He X, Semenov M, Tamai K, Zeng X.

Development. 2004 Apr;131(8):1663-77. Review.

10.

Wnt signaling in angiogenesis.

Parmalee NL, Kitajewski J.

Curr Drug Targets. 2008 Jul;9(7):558-64. Review.

11.

The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease.

Warden SM, Andreoli CM, Mukai S.

Semin Ophthalmol. 2007 Oct-Dec;22(4):211-7. Review.

PMID:
18097984
12.

Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance?

Malbon CC, Wang H, Moon RT.

Biochem Biophys Res Commun. 2001 Sep 28;287(3):589-93. Review.

PMID:
11563835
13.

Familial exudative vitreoretinopathy and related retinopathies.

Gilmour DF.

Eye (Lond). 2015 Jan;29(1):1-14. doi: 10.1038/eye.2014.70. Epub 2014 Oct 17. Review.

14.

Genetics and molecular biology.

Ikonen E.

Curr Opin Lipidol. 2002 Aug;13(4):441-3. Review. No abstract available.

PMID:
12151859
15.

The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.

Ye X, Wang Y, Nathans J.

Trends Mol Med. 2010 Sep;16(9):417-25. doi: 10.1016/j.molmed.2010.07.003. Epub 2010 Aug 3. Review.

16.

Wnt modulators in the biotech pipeline.

Rey JP, Ellies DL.

Dev Dyn. 2010 Jan;239(1):102-14. doi: 10.1002/dvdy.22181. Review. Erratum in: Dev Dyn. 2010 Mar;239(3):1034.

17.

Retinal neovascular disorders: mouse models for drug development studies.

Yetemian RM, Craft CM.

Adv Exp Med Biol. 2012;723:253-9. doi: 10.1007/978-1-4614-0631-0_33. Review. No abstract available.

PMID:
22183340
18.

The different functions of Norrin.

Braunger BM, Tamm ER.

Adv Exp Med Biol. 2012;723:679-83. doi: 10.1007/978-1-4614-0631-0_86. Review. No abstract available.

PMID:
22183393
19.

Neovascularization: ocular diseases, animal models and therapies.

Cai X, Sezate SA, McGinnis JF.

Adv Exp Med Biol. 2012;723:245-52. doi: 10.1007/978-1-4614-0631-0_32. Review. No abstract available.

PMID:
22183339

Supplemental Content

Support Center